Validation of a bioanalytical HPLC–UV method to quantify Α‐Bisabolol in rat plasma applied to pharmacokinetic pilot study with the drug nanoemulsion

Documenti analoghi

• Rapid identification of potential nonsteroidal anti‐inflammatory drug overdose–induced liver toxicity and prediction of follow‐up exposure: Integrating bioanalytical and population pharmacokinetic assay
  di: Sufeng Zhou, et al.
  Pubblicazione: (2024)
• Simultaneous quantification of icaritin and its novel 3‐methylcarbamate prodrug in rat plasma using HPLC–MS/MS and its application to pharmacokinetic study
  di: Fengxiao Li, et al.
  Pubblicazione: (2024)
• Comparative analysis of six aconitine‐type alkaloids in decocting extracts between the different processed Fuzi (Aconiti Lateralis Radix praeparata) and its pharmacokinetic behavior in rats by HPLC‐MS/MS
  di: Baodong Feng, et al.
  Pubblicazione: (2024)
• Impact of introducing a new biological matrix into a validated bioanalytical method: Focus on matrix protein content
  di: Stacy D. Brown
  Pubblicazione: (2024)
• Spectroscopic characterization and pharmacokinetic evaluation of amorphous solid dispersions of glibenclamide for bioavailability enhancement in Wistar rats
  di: Khalid Bashir Mir, et al.
  Pubblicazione: (2024)